Animal Health Market Size, Trends, Growth, CAGR Status, Revenue and Future Outlook
Animal Health Market Growth, Size, Trends Analysis - By Product, By Animal Type, By Distribution Channel, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Mar-2025 | Report ID: HLCA2595 | Pages: 1 - 272 | Formats*: |
| Category : Healthcare | |||
Animal Health Market Introduction and Overview
According to SPER Market Research, the Global Animal Health Market is estimated to reach USD 174.43 billion by 2034 with a CAGR of 10.74%.
The report includes an in-depth analysis of the Global Animal Health Market, including market size and trends, product mix, Applications, and supplier analysis.
Pharmaceuticals, vaccinations, diagnostic tools, and feed additives are all part of the animal health business, which aims to prevent and treat illnesses in companion animals and cattle. Increased pet ownership, rising demand for foods derived from animals, and increased awareness of zoonotic illnesses are the main factors propelling the market's expansion. Developments in veterinary care, like biotechnology-based therapies and precise diagnostics, also support growth. Growth is impeded by obstacles such as strict regulatory approvals, costly R&D expenses, and restricted access to veterinary care in underdeveloped nations. Risks also include worries about fake medications and the rise in antibiotic resistance. Notwithstanding these challenges, government programs and continuous advancements to improve animal healthcare are driving market expansion.
By Product Insights: Animal Health is classified into six categories based on Product: Biologics, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment & Disposables, Others. The market was dominated by the pharmaceutical sector. Due to steady improvements in veterinary medications, it is anticipated to maintain its leading position for the duration of the projected period. In the near future, the other segment which includes veterinary software, veterinary telehealth, and livestock monitoring solutions is anticipated to expand at the highest rate. The use of telehealth apps and software to enable virtual interactions between patients and veterinarians increased dramatically during the outbreak.
By Animal Type Insights: The market for Animal Health is segmented based on Animal Type, including Production Animals, Companion Animals. The market was led by the production animal sector, which also had the biggest revenue share. Increased end-user and market stakeholder concerns about food sustainability and safety, including government healthcare institutions, are the cause of the significant segment share. During the projected period, the companion animal category is anticipated to increase at a profitable pace. This can be attributed to rising pet insurance rates, pet humanization, pet spending, and the pace of medicalization.
By Distribution Channel Insights: The market for Animal Health is segmented based on Distribution Channel, including Retail, E-Commerce, Hospital/ Clinic Pharmacy. The biggest revenue share in terms of distribution channels was held by the hospital/clinic pharmacy segment. The segment's expansion has been aided by the rising number of hospital pharmacies and the high amount of procedures. Furthermore, as they are prescriptions, e-commerce channels provide for a steady supply of drugs, which can be reordered. These kinds of advantages are expected to boost e-commerce demand over the course of the projected period.
By End User Insights: The market for Animal Health is divided into many end users, including Veterinary Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others. The largest portion of income was generated by the veterinary clinics and hospitals segment. This is because there are so many clinics and hospitals in the world, and the most patients go to these facilities. In contrast, the point-of-care testing/in-house testing segment is anticipated to expand at the fastest rate. The point-of-care testing and in-house testing segments will be driven in the upcoming years by the anticipated rise in zoonotic disease occurrences, which will raise the demand for diagnostic procedures.
By Regional Insights: The largest share of the animal health market was in North America. Large-scale animal mortality due to zoonotic and livestock diseases are the main causes of the dominant share. Furthermore, the substantial share can be attributed to a number of variables, including the existence of major market competitors, sophisticated healthcare infrastructure, and high healthcare spending. Furthermore, it is believed that the presence of medical services and initiatives to promote animal health increases the area's growth potential.
Market Competitive Landscape
The market is extremely competitive and fragmented. This is because there are so many businesses. A significant portion of the dynamic and changing animal health sector is occupied by businesses that are highly skilled in product development, market analysis, strategic decision-making, and regulatory compliance. Some of the key market players are Zoetis, Ceva Santé Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim GmbH, Elanco, Virbac, Mars Inc., Dechra Pharmaceuticals plc, IDEXX Laboratories, Inc.
Recent Developments:
- In October 2024, Expanded Access Programs (EAPs) for dogs and animals were launched by VMD Sciences to give veterinarians access to innovative, life-saving therapies that are frequently inaccessible through traditional routes.
- In November 2023, Bimeda increased its capabilities by building a new manufacturing plant in China for parasite-control medicines and sterile injections.
- In October 2023, Librela, an anti-NGF monoclonal antibody therapy created by Zoetis, was commercially launched in the United States to alleviate the pain associated with osteoarthritis in dogs.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Animal Type, By Distribution Channel, By End User. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Zoetis, Ceva Santé Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim GmbH, Elanco, Virbac, Mars Inc., Dechra Pharmaceuticals plc, IDEXX Laboratories, Inc. |
Key Topics Covered in the Report
- Global Animal Health Market Size (FY’2021-FY’2034)
- Overview of Global Animal Health Market
- Segmentation of Global Animal Health Market By Product (Biologics, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment & Disposables, Others)
- Segmentation of Global Animal Health Market By Animal Type (Production Animals, Companion Animals)
- Segmentation of Global Animal Health Market By Distribution Channel (Retail, E-Commerce, Hospital/ Clinic Pharmacy)
- Segmentation of Global Animal Health Market By End User (Veterinary Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others)
- Statistical Snap of Global Animal Health Market
- Expansion Analysis of Global Animal Health Market
- Problems and Obstacles in Global Animal Health Market
- Competitive Landscape in the Global Animal Health Market
- Details on Current Investment in Global Animal Health Market
- Competitive Analysis of Global Animal Health Market
- Prominent Players in the Global Animal Health Market
- SWOT Analysis of Global Animal Health Market
- Global Animal Health Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Animal Health Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Animal Health Market
7. Global Animal Health Market, By Product 2021-2034 (USD Million)
7.1. Biologics
7.1.1. Vaccines7.1.2. Other Biologics
7.2. Pharmaceuticals
7.2.1. Parasiticides7.2.2. Anti-infectives7.2.3. Anti-inflammatory7.2.4. Analgesics7.2.5. Others
7.3. Medicinal Feed Additives7.4. Diagnostics
7.4.1. Consumables, reagents and kits7.4.2. Instruments and devices
7.5. Equipment & Disposables
7.5.1. Critical Care Consumables7.5.2. Anesthesia Equipment7.5.3. Fluid Management Equipment7.5.4. Temperature Management Equipment7.5.5. Rescue & Resuscitation Equipment7.5.6. Research Equipment7.5.7. Patient Monitoring Equipment
7.6. Others
7.6.1. Veterinary Telehealth7.6.2. Veterinary Software7.6.3. Livestock Monitoring
8. Global Animal Health Market, By Animal Type 2021-2034 (USD Million)
8.1. Production Animals
8.1.1. Poultry8.1.2. Swine8.1.3. Cattle8.1.4. Sheep & Goats8.1.5. Fish
8.2. Companion Animals
8.2.1. Dogs8.2.2. Cats8.2.3. Horses8.2.4. Others
9. Global Animal Health Market, By Distribution Channel 2021-2034 (USD Million)
9.1. Retail9.2. E-Commerce9.3. Hospital/ Clinic Pharmacy
10. Global Animal Health Market, By End User 2021-2034 (USD Million)
10.1. Veterinary Reference Laboratories10.2. Point-of-care Testing/In-house Testing10.3. Veterinary Hospitals & Clinics10.4. Others
11. Global Animal Health Market, 2021-2034 (USD Million)
11.1. Global Animal Health Market Size and Market Share
12. Global Animal Health Market, By Region, 2021-2034 (USD Million)
12.1. Asia-Pacific
12.1.1. Australia12.1.2. China12.1.3. India12.1.4. Japan12.1.5. South Korea12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France12.2.2. Germany12.2.3. Italy12.2.4. Spain12.2.5. United Kingdom12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia12.3.2. United Arab Emirates12.3.3. Qatar12.3.4. South Africa12.3.5. Egypt12.3.6. Morocco12.3.7. Nigeria12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada12.4.2. Mexico12.4.3. United States
12.5. Latin America
12.5.1. Argentina12.5.2. Brazil12.5.3. Rest of Latin America
13. Company Profile
13.1. Boehringer Ingelheim Gmbh
13.1.1. Company details13.1.2. Financial outlook13.1.3. Product summary13.1.4. Recent developments
13.2. Ceva Santé Animale
13.2.1. Company details13.2.2. Financial outlook13.2.3. Product summary13.2.4. Recent developments
13.3. Dechra Pharmaceuticals Plc
13.3.1. Company details13.3.2. Financial outlook13.3.3. Product summary13.3.4. Recent developments
13.4. Elanco
13.4.1. Company details13.4.2. Financial outlook13.4.3. Product summary13.4.4. Recent developments
13.5. Idexx Laboratories, Inc.
13.5.1. Company details13.5.2. Financial outlook13.5.3. Product summary13.5.4. Recent developments
13.6. Mars Inc.
13.6.1. Company details13.6.2. Financial outlook13.6.3. Product summary13.6.4. Recent developments
13.7. Merck & Co., Inc.
13.7.1. Company details13.7.2. Financial outlook13.7.3. Product summary13.7.4. Recent developments
13.8. Vetoquinol S.A.
13.8.1. Company details13.8.2. Financial outlook13.8.3. Product summary13.8.4. Recent developments
13.9. Virbac
13.9.1. Company details13.9.2. Financial outlook13.9.3. Product summary13.9.4. Recent developments
13.10. Zoetis
13.10.1. Company details13.10.2. Financial outlook13.10.3. Product summary13.10.4. Recent developments
13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Animal Health Market is projected to reach USD 174.43 billion by 2034, growing at a CAGR of 10.74% during the forecast period.
Animal Health Market grew in Market size from 2025. The Market is expected to reach USD 174.43 billion by 2034, at a CAGR of 10.74% during the forecast period.
Animal Health Market CAGR of 10.74% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Animal Health Market size is USD 174.43 billion from 2025 to 2034.
Animal Health Market is covered By Product, By Function, By Application, By End-User.
The North America is anticipated to have the highest Market share in the Animal Health Market.
The key players in the Market include Companies Covered Zoetis, Ceva Santé Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim GmbH, Elanco, Virbac, Mars Inc., Dechra Pharmaceuticals plc, IDEXX Laboratories, Inc.
Pharmaceuticals, vaccinations, diagnostic tools, and feed additives are all part of the animal health business, which aims to prevent and treat illnesses in companion animals and cattle. Increased pet ownership, rising demand for foods derived from animals, and increased awareness of zoonotic illnesses are the main factors propelling the market's expansion.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
